Tushar Garg, DO
Family Medicine · Everett, WANPI 1184104218
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (57.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Medtronic at 57.9% of the total. 2022 is the largest year on record at $1,629, more than ten times the $39 reported in 2019. Among family medicine clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 16 payments — averaging $115.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Siemens Medical Solutions USA, Inc.$462
- Boston Scientific$96
- Pfizer$45
- E.r. Squibb & Sons, L.L.C.$43
- AstraZeneca$32
- plus $100 from 5 others
What the payments were for
- Grants$1,07158%
- Travel & lodging$46225%
- Food & beverage$31617%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 1 | $1,071 |
| Siemens Medical Solutions USA, Inc. | 1 | $462 |
| Boston Scientific | 1 | $96 |
| Pfizer | 3 | $45 |
| E.r. Squibb & Sons, L.L.C. | 2 | $43 |
| AstraZeneca | 2 | $32 |
| Boehringer Ingelheim | 2 | $30 |
| Genentech, Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $19 |
| Merck | 1 | $15 |
| GSK | 1 | $15 |
How this compares
$1,849 in reported general payments places this provider in the 90th percentile of 2,275 family medicine providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 14 | $110 |
| Azithromycin | 14 | $37 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Everett
- Kevin HatfieldSeattle$527K
- Marta KazymyraBlaine$222K
- Donella YoungDavenport$175K
- Robert McIntyreSeattle$107K
- James MorenBellingham$106K
- Marshall BrownPasco$70K
- Cynthia CoteMaple Valley$66K
- Greg LedgerwoodBrewster$66K
- Daniel RivasBurien$50K
- Kent WalkerSumner$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.